Phase 2 Trials of Checkpoint Inhibitors for Advanced Solid Cancers

This systematic review and meta-analysis evaluates the types of primary end points used in phase 2 checkpoint-inhibitor trials and assesses the strength of associations for objective response rate with progression-free and overall survival.

from Cancer via ola Kala on Inoreader http://ift.tt/2sIKxMm
via IFTTT